Tildifort 18 %
The drug is used for the treatment of cattle and pigs with diseases of the respiratory system (actinobacillary pleuropneumonia, Haemophilus polyserositis, pasteurellosis, bordetellosis, and atrophic rhinitis) and other infections of bacterial etiology, the causative agents of which are sensitive to tildipirosin.
The drug belongs to the antibacterial agents of the macrolide group.
It has antimicrobial activity against: Actinobacillus pleuropneumoniae, Pasteurella multocida, Bordetella bronchiseptica and Haemophilus parasuis. In vitro, the effect of tildipirosin is bacteriostatic against Pasteurella multocida, Bordetella bronchiseptica, and bactericidal against Actinobacillus pleuropneumoniae and Haemophilus parasuis.
| Active ingredients |
In 1 ml of the drug as the active substance contains 180 mg of tildipirosin, excipients. |
| Dosage and administration |
The drug is administered once in the following doses:
|
| Withdrawal periods |
Slaughter of cattle for meat is permitted no earlier than 47 days, pigs - 9 days after the last application of the drug.
Meat from animals forcedly slaughtered before the expiration of the specified periods may be used for feeding carnivorous animals. |
| Presentation |
Dark glass bottles of 100 ml.
|
| Shelf life |
The shelf life of the drug is two years from the date of manufacture, provided that storage conditions are observed; after first opening the packaging - 28 days under the specified storage conditions. |
| Storage conditions |
The drug should be stored and transported in the manufacturer's packaging, in a place protected from light and moisture, at a temperature from 2 °C to 25 °C. |